Back to the Media roomTim McCarthy, Chairman of Immupharma discusses the completion of Lupuzor™ pivotal phase III study and initiation of follow up study. 5th February 2018Share this article Share on Facebook Share on Twitter
Tim McCarthy, Chairman of Immupharma discusses the completion of Lupuzor™ pivotal phase III study and initiation of follow up study. 5th February 2018
